![Anthony Adam Rosenberg](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Anthony Adam Rosenberg
Chairman at
OCULIS HOLDING AG
Net worth: 6 M $ as of 2026-06-29
Profile
Anthony Adam Rosenberg is Chief Executive Officer at TR Advisory Services GmbH since 2015.
He is Chairman at Oculis SA since 2018, Chairman at Cullinan Therapeutics, Inc. since 2020, and Chairman at Oculis Holding AG since 2023.
He serves as Director at Cullinan Mica Corp., SiO2 Medical Products, Inc., and Nuclidium AG.
He is an Independent Non-Executive Director at argenx SE since 2017.
He is Senior Advisor at Kurma Partners SA since 2022.
Former roles include Director at Idenix Pharmaceuticals LLC from 2009 to 2013, Independent Director at Radius Health, Inc. from 2015 to 2020, Managing Director at MPM BioImpact LLC from 2015 to 2020, Independent Director at Cullinan Oncology LLC from 2017 to 2020, Head-Mergers, Acquisitions & Licensing at Novartis International AG from 2012 to 2015, and Global Head-Business Development & Licensing at Novartis Pharmaceuticals Corp.
from 2005 to 2012.
Education includes graduate studies at the University of London and undergraduate studies at the University of Leicester.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
ARGENX SE 0.01% | 2026-06-29 | 3,468 ( 0.01% ) | 3 M $ | 2026-06-29 |
OCULIS HOLDING AG 0.23% | 2025-12-30 | 129,270 ( 0.23% ) | 2 M $ | 2026-06-29 |
| 2026-06-15 | 45,002 ( 0.08% ) | 819 486 $ | 2026-06-29 |
Anthony Adam Rosenberg active positions
| Companies | Position | Start |
|---|---|---|
| ARGENX SE | Director/Board Member | 2017-04-25 |
| CULLINAN THERAPEUTICS, INC. | Chairman | 2020-03-31 |
| OCULIS HOLDING AG | Chairman | 2023-03-02 |
Cullinan Mica Corp.
 Cullinan Mica Corp. Pharmaceuticals: MajorHealth Technology Develops immuno-oncology therapeutics | Director/Board Member | - |
Kurma Partners SA
 Kurma Partners SA Investment ManagersFinance KP invests in startups located in Europe. The firm targets companies operating in the fields of healthcare services and health technologies. It provides financing for seed to growth stage capital requirements. | Consultant / Advisor | 2022-03-06 |
SiO2 Medical Products, Inc.
 SiO2 Medical Products, Inc. Medical SpecialtiesHealth Technology Manufactures syringes, vials and blood tubes | Director/Board Member | - |
Oculis SA
 Oculis SA Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage biopharmaceutical company that focuses on developing treatments for ophthalmic diseases | Chairman | 2018-03-31 |
TR Advisory Services GmbH
 TR Advisory Services GmbH Miscellaneous Commercial ServicesCommercial Services Provides consulting and related services that focus on life science | Chief Executive Officer | 2015-03-31 |
Nuclidium AG
 Nuclidium AG Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops radiopharmaceuticals for treatment of cancer | Director/Board Member | - |
Former positions of Anthony Adam Rosenberg
| Companies | Position | End |
|---|---|---|
| ░░░░░░ ░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░ ░░░░░░░░░ ░░░ | ░░░░░░░ ░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Training of Anthony Adam Rosenberg
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
73
1st degree connections
23
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 23 |
|---|---|
Idenix Pharmaceuticals LLC
 Idenix Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs for the treatment of human viral and infectious diseases caused by hepatitis | Health Technology |
Novartis International AG
 Novartis International AG Pharmaceuticals: MajorHealth Technology Offers healthcare solutions | Health Technology |
Genoptix, Inc.
 Genoptix, Inc. Medical/Nursing ServicesHealth Services Provides cancer laboratory testing services | Health Services |
Radius Health, Inc.
 Radius Health, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops and commercializes bone health and related therapeutics | Health Technology |
Clinical Ink, Inc.
 Clinical Ink, Inc. Internet Software/ServicesTechnology Services Operates as an eSource platform and provides clinical trial solutions | Technology Services |
MPM BioImpact LLC
 MPM BioImpact LLC Investment ManagersFinance MPM Capital invests in both public and private companies located in the United States. The firm targets companies operating in the fields of biotechnology, healthcare and life science sectors. It participates in early stage capital transactions. | Finance |
University of London
 University of London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions | Health Technology |
University of Leicester
 University of Leicester Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
argenx SE
 argenx SE BiotechnologyHealth Technology Develops therapies and medicines for the treatment of autoimmune diseases | Health Technology |
Kurma Partners SA
Kurma Partners SA Investment ManagersFinance KP invests in startups located in Europe. The firm targets companies operating in the fields of healthcare services and health technologies. It provides financing for seed to growth stage capital requirements. | Finance |
SiO2 Medical Products, Inc.
SiO2 Medical Products, Inc. Medical SpecialtiesHealth Technology Manufactures syringes, vials and blood tubes | Health Technology |
TriNetX, LLC
 TriNetX, LLC Data Processing ServicesTechnology Services Provides healthcare and life science data & platform solutions | Technology Services |
Cullinan Mica Corp.
Cullinan Mica Corp. Pharmaceuticals: MajorHealth Technology Develops immuno-oncology therapeutics | Health Technology |
Oculis SA
Oculis SA Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage biopharmaceutical company that focuses on developing treatments for ophthalmic diseases | Commercial Services |
iOmx Therapeutics AG
 iOmx Therapeutics AG BiotechnologyHealth Technology Develops immunotherapy treatments for cancer patients | Health Technology |
Cullinan Oncology LLC
 Cullinan Oncology LLC Financial ConglomeratesFinance Provides investment services for cancer treatments | Finance |
TR Advisory Services GmbH
TR Advisory Services GmbH Miscellaneous Commercial ServicesCommercial Services Provides consulting and related services that focus on life science | Commercial Services |
Cullinan Oncology, Inc.
 Cullinan Oncology, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
European Biotech Acquisition Corp.
 European Biotech Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Nuclidium AG
Nuclidium AG Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops radiopharmaceuticals for treatment of cancer | Health Technology |
Oculis Holding AG
 Oculis Holding AG Miscellaneous Commercial ServicesCommercial Services Operates as a global biopharmaceutical company that develops novel therapeutics to treat ophthalmic diseases | Commercial Services |
Clinincal Ink, Inc. |
- Stock Market
- Insiders
- Anthony Adam Rosenberg
Choose MarketScreener 
